Ericson William W.

Director at PACIFIC BIOSCIENCES OF CALIFORNIA, INC. · on record since Oct 27, 2010
10% owner at Rally Software Development Corp · on record since Apr 18, 2013
Director at Rocket Fuel Inc. · on record since Sep 27, 2013
10% owner at Rocket Fuel Inc. · on record since Sep 27, 2013
Director at Adamas Pharmaceuticals Inc · on record since Apr 15, 2014
10% owner at Adamas Pharmaceuticals Inc · on record since Apr 15, 2014
10% owner at Quotient Technology Inc. · on record since Oct 14, 2016
10% owner at Personalis, Inc. · on record since Jun 26, 2019

Insider trading activity of Ericson William W.

Transactions on record: 115; since Oct 27, 2010

Open-market buys: 24; $13.8M

Open-market sells: 16; $152.7M

Companies traded: 4; last filing Jun 4, 2026

Figures computed from official regulatory filings — .

Companies where Ericson William W. has traded

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.47 tx · $8.5M · Jun 4, 2026
Adamas Pharmaceuticals Inc46 tx · $13.4M · Nov 24, 2021
Rocket Fuel Inc.21 tx · $114M · Sep 6, 2017
Rally Software Development Corp1 tx · $33.1M · Jul 31, 2013

Track record of Ericson William W.

Statistical track record

Free account

Open-market buys: 24

Last buy: Sep 16, 2016

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Ericson William W.

Co-insiders of Ericson William W.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Jun 4, 2026	AwardD (derivative)	223,492	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Jun 6, 2025	AwardD (derivative)	65,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Jun 20, 2024	AwardD (derivative)	32,179	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Jun 20, 2024	Award	22,821	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	May 26, 2023	AwardD (derivative)	25,775	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Mar 17, 2023	Exercise	25,000	2.54 USD	$63.5K	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Mar 17, 2023	Sell	-7,541	8.90 USD	$67.1K	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Mar 17, 2023	ExerciseD (derivative)	-25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	May 27, 2022	AwardD (derivative)	63,015	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Apr 13, 2022	Other	-4,848,397	—	n/a (No price was disclosed in the filing)	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Apr 13, 2022	Other	68	—	n/a (No price was disclosed in the filing)	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Apr 13, 2022	Other	-750,000	—	n/a (No price was disclosed in the filing)	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Apr 13, 2022	Other	1,268	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	Other	-3,146	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	Other	-25,661	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	Other	-4,031,804	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	Other	-287,992	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	OtherD (derivative)	-10,000	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	Other	-265,150	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	Other	-10,000	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	OtherD (derivative)	-10,000	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	Other	-6,043	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	OtherD (derivative)	-10,000	—	n/a (No price was disclosed in the filing)	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Jun 21, 2021	AwardD (derivative)	12,885	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adamas Pharmaceuticals IncListing unverified	Jun 4, 2021	Award	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Jun 4, 2026	AwardD (derivative)	223,492	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Jun 6, 2025	AwardD (derivative)	65,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Jun 20, 2024	AwardD (derivative)	32,179	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Jun 20, 2024	Award	22,821	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	May 26, 2023	AwardD (derivative)	25,775	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Mar 17, 2023	Exercise	25,000	2.54 USD	$63.5K	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Mar 17, 2023	Sell	-7,541	8.90 USD	$67.1K	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Mar 17, 2023	ExerciseD (derivative)	-25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	May 27, 2022	AwardD (derivative)	63,015	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Apr 13, 2022	Other	-4,848,397	—	n/a (No price was disclosed in the filing)	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Apr 13, 2022	Other	68	—	n/a (No price was disclosed in the filing)	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Apr 13, 2022	Other	-750,000	—	n/a (No price was disclosed in the filing)	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Apr 13, 2022	Other	1,268	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	Other	-3,146	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	Other	-25,661	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	Other	-4,031,804	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	Other	-287,992	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	OtherD (derivative)	-10,000	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	Other	-265,150	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	Other	-10,000	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	OtherD (derivative)	-10,000	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	Other	-6,043	—	n/a (No price was disclosed in the filing)	SEC
Adamas Pharmaceuticals IncListing unverified	Nov 24, 2021	OtherD (derivative)	-10,000	—	n/a (No price was disclosed in the filing)	SEC
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Listing on record	Jun 21, 2021	AwardD (derivative)	12,885	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adamas Pharmaceuticals IncListing unverified	Jun 4, 2021	Award	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC